Welcome to hospitalpharma.com
Post Your Own Content
Latest News
- Training a hospitalist workforce to address the intensivist shortage in american hospitals: A position paper from the society of hospital medicine and the society of critical care medicine
- UK-led technologies set to transform treatments on the NHS
- Reports Summarize Gene Therapy Research from Glasgow Caledonian University
- New Renal-Denervation Systems Debut Amid Excitement, Caution
- Medtronic wins expanded EU approval for Resolute stent
Latest Press Releases
- East Lancashire Hospitals NHS Trust orders Ascribe’s ePrescribing and Business Change Consultancy
14 May 12
- SFL’s Managing Director to Moderate Panel Discussion at EuroMedTech event in Grenoble, France
14 May 12
SFL Regulatory Affairs & Scientific Communication - Africa Health hailed as a catalyst for healthcare changes in Africa
14 May 12
- CRS opens research center for early clinical studies on Lübeck Campus of the University Medical Center Schleswig-Holstein
14 May 12
CRS Clinical Research Services Andernach GmbH - Dharamshila Hospital Organized A Live Workshop on Composite Resection with Micro vascular Free Fibular Flap Reconstruction
12 May 12
Dharamshila Hospital and Research Centre
Latest Events
HospitalPharma.com today | 19 May 2012
Canada OKs Osiris drug; first stem cell therapy
Osiris Therapeutics Inc said on Thursday that Canadian health regulators have approved its treatment for acute graft-versus host disease in children, making it the first stem cell drug to be approved for a systemic disease anywhere in the world.
Osiris shares rose 14 percent to $6.00 in extended trading after the news was announced.
"I am very proud of the leadership role Canada has taken in advancing stem cell therapy and particularly gratified that this historic decision benefits children who would otherwise have little hope," said Andrew Daly, M.D., Clinical Associate Professor, Department of Medicine and Oncology at the University of Calgary, Canada and Principal Investigator in the phase 3 clinical program for Prochymal. "As a result of Health Canada's comprehensive review, physicians now have an off-the-shelf stem cell therapy in their arsenal to fight GvHD. Much like the introduction of antibiotics in the late 1920's, with stem cells we have now officially taken the first step into this new paradigm of medicine."
Breaking Drug Discovery Articles
Click the 'more' link below to be taken to the latest journal article entries in the area of drug discovery, provided by http://www.leaddiscovery.co.uk.
Latest Features
What is a Brand Manager?
11 May 12
Pharmaceutical brand managers have the task of bringing success to a brand's lifecycle.
Titian to Provide Roche with Mosaic™ Software for Managing its Global Sample Banks
15 Feb 12
Ordering, management and workflow efficiency to be optimized using industry-favored software solution
How to stop recruiters throwing out your CV
20 Jan 12
Recruiters are very busy people, and typically have little time to read and select CVs for any given role.
Latest Poll
